RestorFlora

RestorFlora 21 Capsules is a four-strain probiotic providing 8 billion CFU per serving through a combination of one probiotic yeast and three spore-forming Bacillus bacteria: Saccharomyces boulardii, Bacillus subtilis HU58™, Bacillus coagulans SC-208, and Bacillus clausii SC-109. The 21-capsule count is designed for short-term use, travel, or initial trial — delivering the same complete formula as the 50-capsule size in a three-week supply at one capsule daily. It is commonly used during or after antibiotic therapy, periods of travel or dietary disruption, or any circumstance in which gut microbial balance may be temporarily compromised. Capsules may be opened and mixed into food or non-carbonated beverages for those who prefer not to swallow them whole.

What distinguishes RestorFlora from single-strain or bacteria-only probiotic products is its dual-kingdom approach — combining a probiotic yeast with spore-forming bacterial strains that each contribute distinct and complementary mechanisms. Saccharomyces boulardii is one of the most extensively clinically studied probiotic organisms in the world, with a well-documented history of use for supporting digestive comfort and immune function, particularly during and after antibiotic use. Unlike bacterial probiotics, S. boulardii is a yeast and is therefore inherently unaffected by antibiotics that target bacteria, making it a reliable performer in disrupted gut environments. The three Bacillus strains — HU58™, SC-208, and SC-109 — are spore-forming organisms that encapsulate in protective endospores capable of withstanding stomach acid, bile, and heat, arriving in the large intestine intact where they germinate and begin exerting their effects on the local microbial environment.

The clinical rationale for combining yeast and spore-forming bacteria in a single formula is that they occupy different ecological niches and act through distinct mechanisms that together provide broader coverage than either approach alone. S. boulardii acts primarily in the upper GI tract and small intestine, producing enzymes, secretory immunoglobulins, and short-chain fatty acids while competing with pathogenic organisms for adhesion sites on intestinal epithelial cells. The Bacillus strains colonize further down in the large intestine, where they modulate microbiome composition, support intestinal barrier integrity, and produce antimicrobial compounds that favor beneficial commensal bacteria. Published research on the RestorFlora strain combination (studied as MegaDuo™) demonstrated support for intestinal epithelial barrier function and immune function in a two-week trial, making the 21-capsule size a practical fit for short-course gut restoration protocols or as a travel companion during periods of dietary or microbial disruption.